Home / Lifestyle / Health & Fitness / Article / US FDA approves landmark pancreatic cancer drug that's shown to improve survival

US FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumour growth in more than 90 per cent of pancreatic cancer cases. It's an approach that previously eluded drugmakers for decades

  • WhatsAppBookmarkBookmark
Listen to this article :
Image for representational purpose only. Photo Courtesy: File pic

Image for representational purpose only. Photo Courtesy: File pic

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of cancer.

FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumour growth in more than 90 per cent of pancreatic cancer cases. It's an approach that previously eluded drugmakers for decades.

Read Next Story
Faridabad doctors save life of woman with rare life-threatening trauma due to a devastating accident›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All